NEW YORK (360Dx) – King's College London researchers are developing a point-of-care blood test to diagnose heart attacks that uses cardiac myosin-binding protein C as an alternative biomarker to high-sensitivity troponin used in laboratory testing.
Presenting the results of a study last week at the British Cardiovascular Society Conference in Manchester, UK, the researchers said that levels of cMyC in the blood increased more rapidly after patients had a heart attack than in the lab-based troponin tests, which take a few hours to show results.